Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/14/01  and contains information from public web pages.

Dr. Colin N. Scott

Wrong Dr. Colin N. Scott?
 
Background

Employment History

  • Vice President, Clinical Affairs
    Emisphere Technologies , Inc.
  • Vice President, Clinical and Regulatory Affairs
    Cytomed Inc.
  • Director, Medical Affairs
    ASTA Medica AG
  • Director of Medical Affairs
    Muro/ASTA Medica , Inc.
  • Muro/ASTA Medica , Inc. Division

Education

  • M.D.
  • medical degree
    Glasgow University
6 Total References
Web References
PharmaLive
www.medadnews.com, 14 June 2001 [cached]
In addition , Emisphere also announced the appointment of Colin N. Scott , M.D. , to the position of Vice President , Clinical Affairs.
Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere , and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations , and for the clinical development of the Company's platform drug delivery technology.Dr. Scott's experience includes managing , executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica , Inc. , a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG , headquartered in Frankfurt , Germany , where he held the position of Director , Medical Affairs.Previously , Dr. Scott was Vice President , Clinical and Regulatory Affairs at CytoMed , Inc..Dr. Scott received his medical degree from Glasgow University , Scotland.
Emisphere Technologies, Inc. - Emisphere Receives Patent Covering Oral Parathyroid Hormone Composition With Lilly
ir.emisphere.com [cached]
In addition, Emisphere also announced the appointment of Colin N. Scott, M.D., to the position of Vice President, Clinical Affairs.
Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere, and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations, and for the clinical development of the Company's platform drug delivery technology. Dr. Scott's experience includes managing, executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica, Inc., a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG, headquartered in Frankfurt, Germany, where he held the position of Director, Medical Affairs. Previously, Dr. Scott was Vice President, Clinical and Regulatory Affairs at CytoMed, Inc. Dr. Scott received his medical degree from Glasgow University, Scotland.
...
We are pleased that Dr. Scott has joined at this exciting time, to lead our efforts as we expand and advance multiple products into the clinic this year. His clinical affairs expertise will also help to establish a long-term clinical development strategy for our earlier-stage product candidates. We look forward to Dr. Scott's participation in creating the clinical infrastructure necessary to capture the potential of Emisphere's product pipeline."
Smartmoney.com: News Search: Emisphere Gets Oral Parathyroid Hormone Composition Patent
www.smartmoneymag.com, 14 June 2001 [cached]
Biopharmaceutical company Emisphere also named Colin N. Scott vice president of clinical affairs.Scott was director of medical affairs for Muro/ASTA Medica Inc. , a unit of ASTA Medica AG's Rx-Healthcare Division.
Company Web site : http : //www.emisphere.com
-Eamon Beltran ; Dow Jones Newswires ; 201-938-5400
( This story was originally published by Dow Jones Newswires ).
Emisphere Biosciences - Investor Relations - Investor Relations News Release
phx.corporate-ir.net [cached]
In addition, Emisphere also announced the appointment of Colin N. Scott, M.D., to the position of Vice President, Clinical Affairs.
Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere, and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations, and for the clinical development of the Company's platform drug delivery technology.Dr. Scott's experience includes managing, executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica, Inc., a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG, headquartered in Frankfurt, Germany, where he held the position of Director, Medical Affairs.Previously, Dr. Scott was Vice President, Clinical and Regulatory Affairs at CytoMed, Inc.Dr. Scott received his medical degree from Glasgow University, Scotland.
...
We are pleased that Dr. Scott has joined at this exciting time, to lead our efforts as we expand and advance multiple products into the clinic this year.His clinical affairs expertise will also help to establish a long-term clinical development strategy for our earlier-stage product candidates.We look forward to Dr. Scott's participation in creating the clinical infrastructure necessary to capture the potential of Emisphere's product pipeline."
Emisphere Technologies, Inc. Investor Relations
www.corporate-ir.net, 14 June 2001 [cached]
In addition, Emisphere also announced the appointment of Colin N. Scott, M.D., to the position of Vice President, Clinical Affairs.
Dr. Scott brings over 20 years of clinical program development expertise in a variety of therapeutic areas to Emisphere, and will be responsible for overseeing the development of all clinical programs to obtain and maintain product registrations, and for the clinical development of the Company's platform drug delivery technology.Dr. Scott's experience includes managing, executing and designing clinical trials in all phases of development through pre-launch.
Dr. Scott joins Emisphere from Muro/ASTA Medica, Inc., a wholly owned subsidiary of the Rx-Healthcare Division of ASTA Medica AG, headquartered in Frankfurt, Germany, where he held the position of Director, Medical Affairs.Previously, Dr. Scott was Vice President, Clinical and Regulatory Affairs at CytoMed, Inc.Dr. Scott received his medical degree from Glasgow University, Scotland.
...
We are pleased that Dr. Scott has joined at this exciting time, to lead our efforts as we expand and advance multiple products into the clinic this year.
Other People with the name "Scott":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304